Mannose 6-phosphate receptor is reduced in -synuclein overexpressing models of parkinsons disease

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Matrone, Carmela ^a   Dzamko, Nicolas ^b,c   Madsen, Peder ^a,d   Nyegaard, Mette ^a   Pohlmann, Regina ^e   Søndergaard, Rikke V ^d,f   Lassen, Louise B ^a   Andresen, Thomas L ^d,f   Halliday, Glenda M ^b   Jensen, Poul Henning ^a   Nielsen, Morten S ^a,d  

^a AARHUS UNIVERSITY   (Denmark)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Lundbeck Foundation   (Denmark)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; CATHEPSIN D; SOMATOMEDIN B RECEPTOR; MESSENGER RNA;

AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BIOACCUMULATION; CELL FRACTIONATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENDOSOME; FEMALE; HUMAN; HUMAN TISSUE; LYSOSOME; MALE; MOUSE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; TRANS GOLGI NETWORK; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

AGED; ALPHA-SYNUCLEIN; ANIMALS; AUTOPHAGY; BIOMARKERS; BRAIN; CATHEPSIN D; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; HUMANS; LYSOSOMES; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; PARKINSON DISEASE; RECEPTOR, IGF TYPE 2; RNA, MESSENGER; TRANS-GOLGI NETWORK;

EID: 84983446952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160501     Document Type: Article

References (65)

1. Guo JL, Lee VM. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nature medicine. 2014;20(2: ):130-8. doi: 10.1038/nm.3457 PMID: 24504409; PubMed Central PMCID: PMC4011661.
2. Kirik D, Gai WP, Jensen PH. Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration? Experimental neurology. 2008;209(1: ):3-4. doi: 10.1016/j.expneurol.2007.12.007 PMID: 18179907.
3. Forman MS, Lee VM, Trojanowski JQ. Nosology of Parkinson's disease: looking for the way out of a quagmire. Neuron. 2005;47(4: ):479-82. doi: 10.1016/j.neuron.2005.07.021 PMID: 16102530.
4. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12: ):1863-72. doi: 10.1212/01.wnl.0000187889.17253.b1 PMID: 16237129.
5. Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, et al. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain: a journal of neurology. 2014;137(Pt 9: ):2493-508. doi: 10.1093/brain/awu193 PMID: 25062696.
6. Jakobsen LD, Jensen PH. Parkinson's disease: alpha-synuclein and parkin in protein aggregation and the reversal of unfolded protein stress. Methods in molecular biology. 2003;232:57-66. doi: 10.1385/1-59259-394-1:57 PMID: 12840539.
7. Bobela W, Aebischer P, Schneider BL. Alphalpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease. Biomolecules. 2015;5(4: ):2675-700. doi: 10.3390/biom5042675 PMID: 26501339; PubMed Central PMCID: PMCPMC4693253.
8. Hardy J, Cookson MR, Singleton A. Genes and parkinsonism. The Lancet Neurology. 2003;2(4: ):221-8. PMID: 12849210.
9. Lykkebo S, Jensen PH. Alpha-synuclein and presynaptic function: implications for Parkinson's disease. Neuromolecular medicine. 2002;2(2: ):115-29. doi: 10.1385/NMM:2:2:115 PMID: 12428807.
10. Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang Y, Hay JC. Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol Biol Cell. 2010;21(11: ):1850-63. doi: 10.1091/mbc.E09-09-0801 PMID: 20392839; PubMed Central PMCID: PMCPMC2877643.
11. Burré J, Sharma M, Südhof TC. Definition of a molecular pathway mediating α-synuclein neurotoxicity. J Neurosci. 2015;35(13: ):5221-32. doi: 10.1523/JNEUROSCI.4650-14.2015 PMID: 25834048; PubMed Central PMCID: PMCPMC4380997.
12. Burré J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Südhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329(5999: ):1663-7. doi: 10.1126/ science.1195227 PMID: 20798282; PubMed Central PMCID: PMCPMC3235365.
13. Vargas KJ, Makani S, Davis T, Westphal CH, Castillo PE, Chandra SS. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci. 2014;34(28: ):9364-76. doi: 10.1523/JNEUROSCI.4787-13.2014 PMID: 25009269; PubMed Central PMCID: PMCPMC4087213.
14. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008;283(14: ):9089-100. doi: 10.1074/jbc.M710012200 PMID: 18245082; PubMed Central PMCID: PMCPMC2431021.
15. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alphasynuclein by chaperone-mediated autophagy. Science. 2004;305(5688: ):1292-5. doi: 10.1126/ science.1101738 PMID: 15333840.
16. Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. Endoproteolytic activity of the proteasome. Science. 2003;299(5605: ):408-11. doi: 10.1126/science.1079293 PMID: 12481023; PubMed Central PMCID: PMC3516294.
17. Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, et al. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2011;31(41: ):14508-20. doi: 10.1523/JNEUROSCI.1560-11.2011 PMID: 21994367; PubMed Central PMCID: PMCPMC3587176.
18. Sevlever D, Jiang P, Yen SH. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry. 2008;47(36: ):9678-87. doi: 10.1021/bi800699v PMID: 18702517; PubMed Central PMCID: PMCPMC2630205.
19. Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, et al. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain. 2009;2:5. doi: 10.1186/ 1756-6606-2-5 PMID: 19203374; PubMed Central PMCID: PMCPMC2644690.
20. Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol Brain. 2008;1:17. doi: 10. 1186/1756-6606-1-17 PMID: 19021916; PubMed Central PMCID: PMCPMC2600785.
21. Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain: a journal of neurology. 2008;131(Pt 8: ):1969-78. doi: 10. 1093/brain/awm318 PMID: 18187492.
22. Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, et al. Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain: a journal of neurology. 2014;137(Pt 3: ):834-48. doi: 10.1093/brain/awt367 PMID: 24477431; PubMed Central PMCID: PMC3927701.
23. Fleming SM, Salcedo J, Hutson CB, Rockenstein E, Masliah E, Levine MS, et al. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience. 2006;142(4: ):1245-53. doi: 10.1016/j.neuroscience.2006.07.005 PMID: 16934409; PubMed Central PMCID: PMC3108485.
24. Petit GH, Berkovich E, Hickery M, Kallunki P, Fog K, Fitzer-Attas C, et al. Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease. PloS one. 2013;8(4: ):e60691. doi: 10.1371/journal.pone.0060691 PMID: 23573275; PubMed Central PMCID: PMC3616111.
25. Westerlund M, Ran C, Borgkvist A, Sterky FH, Lindqvist E, Lundstromer K, et al. Lrrk2 and alpha-synuclein are co-regulated in rodent striatum. Molecular and cellular neurosciences. 2008;39(4: ):586-91. doi: 10.1016/j.mcn.2008.08.001 PMID: 18790059.
26. Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P. NGF and BDNF signaling control amyloidogenic route and Abeta production in hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(35: ):13139-44. doi: 10.1073/pnas.0806133105 PMID: 18728191; PubMed Central PMCID: PMCPMC2525562.
27. Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW. Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. The Journal of biological chemistry. 2003;278(32: ):30005-14. doi: 10. 1074/jbc.M300614200 PMID: 12767974.
28. Matrone C, Di Luzio A, Meli G, D'Aguanno S, Severini C, Ciotti MT, et al. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J Alzheimers Dis. 2008;13(1: ):81-96. PMID: 18334760.
29. Pemberton S, Madiona K, Pieri L, Kabani M, Bousset L, Melki R. Hsc70 protein interaction with soluble and fibrillar alpha-synuclein. The Journal of biological chemistry. 2011;286(40: ):34690-9. doi: 10. 1074/jbc.M111.261321 PMID: 21832061; PubMed Central PMCID: PMCPMC3186418.
30. Jensen PH, Li JY, Dahlstrom A, Dotti CG. Axonal transport of synucleins is mediated by all rate components. The European journal of neuroscience. 1999;11(10: ):3369-76. PMID: 10564344.
31. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. The Journal of biological chemistry. 1998;273(41: ):26292-4. PMID: 9756856.
32. Kasper D, Dittmer F, von Figura K, Pohlmann R. Neither type of mannose 6-phosphate receptor is sufficient for targeting of lysosomal enzymes along intracellular routes. The Journal of cell biology. 1996;134(3: ):615-23. PMID: 8707842; PubMed Central PMCID: PMC2120931.
33. Sondergaard RV, Henriksen JR, Andresen TL. Design, calibration and application of broad-range optical nanosensors for determining intracellular pH. Nature protocols. 2014;9(12: ):2841-58. doi: 10.1038/ nprot.2014.196 PMID: 25411952.
34. Benjaminsen RV, Sun H, Henriksen JR, Christensen NM, Almdal K, Andresen TL. Evaluating nanoparticle sensor design for intracellular pH measurements. ACS nano. 2011;5(7: ):5864-73. doi: 10.1021/ nn201643f PMID: 21707035.
35. La Rosa LR, Perrone L, Nielsen MS, Calissano P, Andersen OM, Matrone C. Y682G Mutation of Amyloid Precursor Protein Promotes Endo-Lysosomal Dysfunction by Disrupting APP-SorLA Interaction. Frontiers in cellular neuroscience. 2015;9:109. doi: 10.3389/fncel.2015.00109 PMID: 25904844; PubMed Central PMCID: PMC4388009.
36. Pepperkok R, Simpson JC, Rietdorf J, Cetin C, Liebel U, Terjung S, et al. Imaging platforms for measurement of membrane trafficking. Methods in enzymology. 2005;404:8-18. doi: 10.1016/S0076-6879 (05)04002-4 PMID: 16413253.
37. Klinger SC, Glerup S, Raarup MK, Mari MC, Nyegaard M, Koster G, et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. Journal of cell science. 2011;124(Pt 7: ):1095-105. doi: 10.1242/jcs.072538 PMID: 21385844.
38. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3-new capabilities and interfaces. Nucleic Acids Res. 2012;40(15: ):e115. doi: 10.1093/nar/gks596 PMID: 22730293; PubMed Central PMCID: PMCPMC3424584.
39. Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Journal of the neurological sciences. 1995;131(1: ):65-70. PMID: 7561949.
40. Kokkonen N, Rivinoja A, Kauppila A, Suokas M, Kellokumpu I, Kellokumpu S. Defective acidification of intracellular organelles results in aberrant secretion of cathepsin D in cancer cells. The Journal of biological chemistry. 2004;279(38: ):39982-8. doi: 10.1074/jbc.M406698200 PMID: 15258139.
41. Platt FM, Boland B, van der Spoel AC. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. The Journal of cell biology. 2012;199(5: ):723-34. doi: 10.1083/ jcb.201208152 PMID: 23185029; PubMed Central PMCID: PMC3514785.
42. Ramonet D, Podhajska A, Stafa K, Sonnay S, Trancikova A, Tsika E, et al. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Human molecular genetics. 2012;21(8: ):1725-43. doi: 10.1093/hmg/ddr606 PMID: 22186024; PubMed Central PMCID: PMC3465694.
43. Stauber T, Jentsch TJ. Chloride in vesicular trafficking and function. Annual review of physiology. 2013;75:453-77. doi: 10.1146/annurev-physiol-030212-183702 PMID: 23092411.
44. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2001;21(24: ):9549-60. PMID: 11739566.
45. Sun H, Almdal K, Andresen TL. Expanding the dynamic measurement range for polymeric nanoparticle pH sensors. Chemical communications. 2011;47(18: ):5268-70. doi: 10.1039/c1cc10439j PMID: 21451849.
46. Nielsen MS, Gustafsen C, Madsen P, Nyengaard JR, Hermey G, Bakke O, et al. Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA. Molecular and cellular biology. 2007;27(19: ):6842-51. doi: 10.1128/MCB.00815-07 PMID: 17646382; PubMed Central PMCID: PMC2099242.
47. Nielsen MS, Madsen P, Christensen EI, Nykjaer A, Gliemann J, Kasper D, et al. The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. The EMBO journal. 2001;20(9: ):2180-90. doi: 10.1093/emboj/20.9.2180 PMID: 11331584; PubMed Central PMCID: PMC125444.
48. Umeda A, Fujita H, Kuronita T, Hirosako K, Himeno M, Tanaka Y. Distribution and trafficking of MPR300 is normal in cells with cholesterol accumulated in late endocytic compartments: evidence for early endosome-to-TGN trafficking of MPR300. Journal of lipid research. 2003;44(10: ):1821-32. doi: 10.1194/jlr.M300153-JLR200 PMID: 12867541.
49. Mari M, Bujny MV, Zeuschner D, Geerts WJ, Griffith J, Petersen CM, et al. SNX1 defines an early endosomal recycling exit for sortilin and mannose 6-phosphate receptors. Traffic. 2008;9(3: ):380-93. doi: 10.1111/j.1600-0854.2007.00686.x PMID: 18088323.
50. Puertollano R, Aguilar RC, Gorshkova I, Crouch RJ, Bonifacino JS. Sorting of mannose 6-phosphate receptors mediated by the GGAs. Science. 2001;292(5522: ):1712-6. doi: 10.1126/science.1060750 PMID: 11387475.
51. Meyer C, Zizioli D, Lausmann S, Eskelinen EL, Hamann J, Saftig P, et al. mu1A-adaptin-deficient mice: lethality, loss of AP-1 binding and rerouting of mannose 6-phosphate receptors. The EMBO journal. 2000;19(10: ):2193-203. doi: 10.1093/emboj/19.10.2193 PMID: 10811610; PubMed Central PMCID: PMC384363.
52. Meyer C, Eskelinen EL, Guruprasad MR, von Figura K, Schu P. Mu 1A deficiency induces a profound increase in MPR300/IGF-II receptor internalization rate. Journal of cell science. 2001;114(Pt 24: ):4469-76. PMID: 11792812.
53. Seaman MN, Marcusson EG, Cereghino JL, Emr SD. Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. The Journal of cell biology. 1997;137(1: ):79-92. PMID: 9105038; PubMed Central PMCID: PMC2139870.
54. Miura E, Hasegawa T, Konno M, Suzuki M, Sugeno N, Fujikake N, et al. VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Neurobiology of disease. 2014;71:1-13. doi: 10.1016/j.nbd.2014.07.014 PMID: 25107340.
55. Tang FL, Erion JR, Tian Y, Liu W, Yin DM, Ye J, et al. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease. J Neurosci. 2015;35(29: ):10613-28. doi: 10.1523/JNEUROSCI.0042-15.2015 PMID: 26203154; PubMed Central PMCID: PMCPMC4510296.
56. Höning S, Griffith J, Geuze HJ, Hunziker W. The tyrosine-based lysosomal targeting signal in lamp-1 mediates sorting into Golgi-derived clathrin-coated vesicles. EMBO J. 1996;15(19: ):5230-9. PMID: 8895568; PubMed Central PMCID: PMCPMC452267.
57. Caplan MJ, Stow JL, Newman AP, Madri J, Anderson HC, Farquhar MG, et al. Dependence on pH of polarized sorting of secreted proteins. Nature. 1987;329(6140: ):632-5. doi: 10.1038/329632a0 PMID: 2821405.
58. Leksa V, Loewe R, Binder B, Schiller HB, Eckerstorfer P, Forster F, et al. Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation. Circulation research. 2011;108(6: ):676-85. doi: 10.1161/CIRCRESAHA.110.234732 PMID: 21273553.
59. Causin C, Waheed A, Braulke T, Junghans U, Maly P, Humbel RE, et al. Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor. The Biochemical journal. 1988;252(3: ):795-9. PMID: 2458716; PubMed Central PMCID: PMC1149217.
60. Struhal W, Presslauer S, Spielberger S, Zimprich A, Auff E, Bruecke T, et al. VPS35 Parkinson's disease phenotype resembles the sporadic disease. J Neural Transm (Vienna). 2014;121(7: ):755-9. doi: 10.1007/s00702-014-1179-1 PMID: 24557499.
61. Zimprich A, Benet-Pages A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89(1: ):168-75. doi: 10.1016/j.ajhg.2011.06.008 PMID: 21763483; PubMed Central PMCID: PMCPMC3135812.
62. Yelamanchili SV, Chaudhuri AD, Flynn CT, Fox HS. Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism. Molecular neurodegeneration. 2011;6:52. doi: 10.1186/ 1750-1326-6-52 PMID: 21777416; PubMed Central PMCID: PMC3160400.
63. Evdokimovskaya Y, Skarga Y, Vrublevskaya V, Morenkov O. Secretion of the heat shock proteins HSP70 and HSC70 by baby hamster kidney (BHK-21) cells. Cell Biol Int. 2010;34(10: ):985-90. doi: 10.1042/CBI20100147 PMID: 20486902.
64. Zinsmaier KE, Bronk P. Molecular chaperones and the regulation of neurotransmitter exocytosis. Biochem Pharmacol. 2001;62(1: ):1-11. PMID: 11377391.
65. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of aging. 2003;24(2: ):197-211. PMID: 12498954.